Top

Fennec Pharmaceuticals Inc.

TSX Exchange | Sep 19, 2019, 5:19 AM EDT | Real-time price

FRX $ 6.45 RT
CHANGE
0.00 (0.00%)
VOLUME
0
Day Low: N/A
Day High: N/A
Detailed Quote
Open: N/A
High: N/A
Beta: 0.6323
Listed Shares Out.1: 19,895,830
Total Shares (All Classes)2: 19,895,830
Prev. Close: 6.45
Low: N/A
VWAP: N/A
Market Cap1: 128,328,104
Market Cap (All Classes)2*: 128,328,104
Dividend: N/A
Div. Frequency: N/A
P/E Ratio: N/A
EPS: -0.90
Yield: N/A
Ex-Div Date: N/A
P/B Ratio: 5.864
Exchange: TSX

(1) Number based only on listed classes of shares.

(2) Number sourced from third party data provider. For the most up to date information, please refer to the company's financial documents.

*Market Capitalization is based on Total Shares Outstanding for all share classes for the company. Convertible bonds and employee stock options that would otherwise be included in the Diluted Shares amount included in a company's filings/financials are not included.

Description

Fennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is primarily engaged in research and development activities. The company is developing Sodium Thiosulfate (STS), a chemo-protectant against hearing loss associated with platinum-based chemotherapy. Its lead product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin induced hearing loss, or ototoxicity in children. More

News Headlines for Fennec Pharmaceuticals Inc.
Fennec Appoints Shubh Goel as Chief Commercial Officer

GlobeNewswire , 6:00 AM EDT September 09, 2019

Fennec Announces Results of Annual Meeting

GlobeNewswire , 6:00 AM EDT June 19, 2019

Research
News Headlines for Fennec Pharmaceuticals Inc.
Fennec Appoints Shubh Goel as Chief Commercial Officer

GlobeNewswire , 6:00 AM EDT September 09, 2019

Fennec Announces Results of Annual Meeting

GlobeNewswire , 6:00 AM EDT June 19, 2019

Last 25 Trades
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. View delay times for all exchanges. Market Data powered by QuoteMedia, Fundamentals by Morningstar. See the QuoteMedia Terms of Use.